Skip to content

Innovative technologies applied to tuberculosis and HIV surveillance

Innovative technologies applied to tuberculosis and HIV surveillance

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-106x5n9j
Enrollment
Unknown
Registered
2022-07-26
Start date
2022-09-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Interventions

Experimental group: 180 people undergoing treatment for Tuberculosis who will use the mobile application called SARA (Self-reported Follow-up for Treatment Aid) to monitor their treatment of the disea

Sponsors

Universidade Federal do Espírito Santo
Lead Sponsor
Universidade Federal do Espírito Santo
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patient over 18 years old with indication for Tuberculosis treatment; patient who has access to a smartphone; patient who agrees to participate in the research

Exclusion criteria

Exclusion criteria: Patients without indication for Tuberculosis treatment; patients deprived of liberty; patients without access to a smartphone; homeless or hospitalized patients; patients with limitations in understanding the application's commands and their functions

Design outcomes

Primary

MeasureTime frame
It is expected to observe greater adherence to tuberculosis treatment in people who will use the SARA (Self-reported Follow-up for Treatment Aid) mobile application.

Secondary

MeasureTime frame
The secondary outcomes evaluated in the study will be: Treatment-related difficulties faced by people with Tuberculosis, such as adverse drug reactions (epigastralgia, pruritus, behavior change, joint pain, peripheral neuropathy, headache, fever, nausea, vomiting , psychosis and seizures), difficulty taking pills, forgetting to take the medication, this outcome will be evaluated from the data obtained in the study questionnaire.;Another secondary outcome that will be evaluated, however in the intervention group, are the difficulties and benefits of inserting the application in the treatment of the person with Tuberculosis, such as internet access, lack of electricity, lack of mastery of technologies, illiteracy, practicality in the use of the application, support in the treatment of Tuberculosis, alarm triggering to take the medication, transmission of information to the health professional, this outcome will be analyzed according to reports obtained by individuals in the intervention group during the application of the follow-up and final questionnaire.

Countries

Brazil

Contacts

Public ContactMariana Araújo

Universidade Federal do Espírito Santo

marianapsaraujo@gmail.com+55 27 3335-7287

Outcome results

None listed

Source: REBEC (via WHO ICTRP)